Expression of Placental Lipid Transporters in Pregnancies Complicated by Gestational and Type 1 Diabetes Mellitus
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25063559 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Paweł Jan Stanirowski und 4 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-015 Warsaw, Poland. Hauptthemen laut MEDLINE: Diabetes, Gestational, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Warsaw.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The objective of the study was to assess the expression of proteins responsible for placental lipid transport in term pregnancies complicated by well-controlled gestational (GDM) and type 1 diabetes mellitus (PGDM). A total of 80 placental samples were obtained from patients diagnosed with PGDM (n = 20), GDM treated with diet (GDMG1, n = 20), GDM treated with diet and insulin (GDMG2, n = 20), and a non-diabetic control group (n = 20). Umbilical and uterine artery blood flows were assessed by means of ultrasound in the period prior to delivery and computer-assisted quantitative morphometry of immunostained placental sections was performed to determine the expression of selected proteins. The morphometric analysis performed for the vascular density-matched placental samples demonstrated a significant increase in the expression of fatty acid translocase (CD36), fatty acid binding proteins (FABP1, FABP4 and FABP5), as well as a decrease in the expression of endothelial lipase (EL) and fatty acid transport protein (FATP4) in the PGDM-complicated pregnancies as compared to the GDMG1 and control groups (p < 0.05). No significant differences with regard to the placental expression of lipoprotein lipase (LPL) and FATP6 protein between GDM/PGDM and non-diabetic patients were noted. Maternal pre-pregnancy weight, body mass index, placental weight as well as the expression of LPL and FABP4 were selected by the linear regression model as the strongest contributors to the fetal birth weight. To conclude, in placentas derived from pregnancies complicated by well-controlled PGDM, the expression of several lipid transporters, including EL, CD36, FATP4, FABP1, FABP4 and FABP5, is altered. Nonetheless, only LPL and FABP4 were significant predictors of the fetal birth weight.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1st Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-015 Warsaw, Poland.
- Department of Biophysics, Physiology and Pathophysiology, Faculty of Health Sciences, Medical University of Warsaw, 02-004 Warsaw, Poland.
- Department of Pathology, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
- Department of Pathology, Professor Witold Orlowski Public Clinical Hospital, Medical Center of Postgraduate Education, 00-416 Warsaw, Poland.
ORCID-Profile: Paweł Jan Stanirowski, Mateusz Wątroba, Dariusz Szukiewicz
Förderung
- Medical University of Warsaw
Zitieren
APA
Stanirowski, P. J., Wątroba, M., Pyzlak, M., Wejman, J., & Szukiewicz, D. (2024). Expression of Placental Lipid Transporters in Pregnancies Complicated by Gestational and Type 1 Diabetes Mellitus. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25063559
Vancouver
Stanirowski PJ, Wątroba M, Pyzlak M, Wejman J, Szukiewicz D. Expression of Placental Lipid Transporters in Pregnancies Complicated by Gestational and Type 1 Diabetes Mellitus. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25063559
BibTeX
@article{Stanirowski2024,
author = {Stanirowski, Paweł Jan and Wątroba, Mateusz and Pyzlak, Michał and Wejman, Jarosław and Szukiewicz, Dariusz},
title = {Expression of Placental Lipid Transporters in Pregnancies Complicated by Gestational and Type 1 Diabetes Mellitus},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25063559}
}
EUVIMED